Structures by: Labd Taha M. O.
Total: 5
1-Benzyl-3-[(1-benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one monohydrate
C24H21N5O,H2O
Acta Crystallographica Section E (2020) 76, 1 95-101
a=9.0872(2)Å b=21.1012(4)Å c=11.7134(2)Å
α=90° β=112.6540(10)° γ=90°
(2<i>Z</i>)-4-Benzyl-2-(2,4-dichlorobenzylidene)-2<i>H</i>-1,4-benzothiazin-3(4<i>H</i>)-one
C22H15Cl2NOS
Acta Crystallographica Section E (2019) 75, 11 1650-1656
a=9.0373(7)Å b=16.6798(13)Å c=12.5110(10)Å
α=90° β=95.982(2)° γ=90°
3,4-Dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine
C20H17N3O3
Acta Crystallographica Section E (2019) 75, 1 94-98
a=10.509(9)Å b=7.435(6)Å c=21.367(16)Å
α=90° β=103.041(15)° γ=90°
3-{(2<i>Z</i>)-2-[(2,4-Dichlorophenyl)methylidene]-3-oxo-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-4-yl}propanenitrile
C18H12Cl2N2OS
Acta Crystallographica Section E (2019) 75, 6 721-727
a=6.5687(6)Å b=7.9971(7)Å c=15.4939(13)Å
α=98.105(4)° β=94.316(4)° γ=95.002(4)°
Dichlorido(3,5,5-trimethyl-1,3'-bi-1<i>H</i>-pyrazole- κ^2^<i>N</i>^2^,<i>N</i>^2'^)copper(II)
C9H12Cl2CuN4
Acta Crystallographica Section E (2011) 67, 3 m323-m324
a=8.5475(2)Å b=9.3475(3)Å c=9.3512(3)Å
α=66.379(2)° β=62.8760(10)° γ=78.065(2)°